Team:Paris Bettencourt/Notebook/Template.html
From 2013.igem.org
(Difference between revisions)
(20 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
<html> | <html> | ||
<head> | <head> | ||
- | <link rel="stylesheet" type="text/css" href="https://2013.igem.org/wiki/index.php?title=Team:Paris_Bettencourt/css/Notebookstyle.css&action= | + | <style type="text/css"> |
+ | #tbnote { | ||
+ | width: 75%; | ||
+ | overflow: auto; | ||
+ | overflow-x: auto; | ||
+ | overflow-y: auto; | ||
+ | } | ||
+ | |||
+ | #tbnote p { | ||
+ | width: 65%; | ||
+ | } | ||
+ | </style> | ||
+ | <!--<link rel="stylesheet" type="text/css" href="https://2013.igem.org/wiki/index.php?title=Team:Paris_Bettencourt/css/Notebookstyle.css&direction=cur&action=raw&ctype=text/css" />--> | ||
</head> | </head> | ||
<body> | <body> | ||
Line 7: | Line 19: | ||
<h2> Drug Screening </h2> | <h2> Drug Screening </h2> | ||
<h3> Day Number <sup>sup</sup> Month </h3> | <h3> Day Number <sup>sup</sup> Month </h3> | ||
- | <a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/ | + | <a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/Trojan_Horse"> |
+ | <img src="https://static.igem.org/mediawiki/2013/0/00/PB_Trojan_Horse_logo.png" height="30px" width="30px"> | ||
</a> | </a> | ||
- | <b> | + | <p><b>sRNA design</b></p> |
- | + | <img src="https://static.igem.org/mediawiki/2013/4/4d/PB_TH_sRNA_Design.png" | |
- | </ | + | width="304" height="228" |
- | < | + | alt="sRNA Design"><br /> |
- | + | <br /> | |
+ | Red sequences:<br /> | ||
+ | <br /> | ||
+ | pACYCDuet-1 (CmR) : <span style="color:red">ATATCCAGTGATTTTTTTCTCCAT</span><br /> | ||
+ | pCOLADuet-1 (KanR) : <span style="color:red">CGTTTCCCGTTGAATATGGCTCAT</span><br /> | ||
+ | <br /> | ||
+ | We decided that targeting only two different antibiotic resistance will be enough for a proof of concept. We give up AmpR because otherwise they might be experimental issues with AmpR that is also on phagemid <em>litmus28i</em>. | ||
</p> | </p> | ||
</div> | </div> | ||
</body> | </body> | ||
</html> | </html> |
Latest revision as of 02:09, 30 July 2013
Drug Screening
Day Number sup Month
sRNA design
Red sequences:
pACYCDuet-1 (CmR) : ATATCCAGTGATTTTTTTCTCCAT
pCOLADuet-1 (KanR) : CGTTTCCCGTTGAATATGGCTCAT
We decided that targeting only two different antibiotic resistance will be enough for a proof of concept. We give up AmpR because otherwise they might be experimental issues with AmpR that is also on phagemid litmus28i.